{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:03:59Z","timestamp":1792184639204,"version":"4.4.0"},"reference-count":19,"publisher":"FapUNIFESP (SciELO)","issue":"3A","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arq. Neuro-Psiquiatr."],"published-print":{"date-parts":[[2000,9]]},"abstract":"<jats:p>Sintomas psicol\u00f3gicos, especialmente ansiedade e depress\u00e3o, t\u00eam sido associados \u00e0 hiperprolactinemia. Para avaliar a presen\u00e7a desses sintomas, foram submetidos \u00e0 entrevista atrav\u00e9s do Composed International Diagnostic Interview, seguido pela escala de Hamilton para depress\u00e3o, 32 pacientes (5 homens e 27 mulheres) com hiperprolactinemia de v\u00e1rias etiologias e 16 normoprolactin\u00eamicos. A prolactina s\u00e9rica na \u00e9poca da avalia\u00e7\u00e3o variou de 28 a 180 ng\/mL, sendo que 11 dos pacientes usavam bromocriptina. Detectou-se presen\u00e7a atual de dist\u00farbios de ansiedade em 18 pacientes (56,2%) e 5 controles (31,2%), depress\u00e3o em 10 pacientes (31,2%) e 2 controles (12,5%), distmia em duas pacientes e outros diagn\u00f3sticos psiqui\u00e1tricos em 6 pacientes (18,7%). Os escores da depress\u00e3o variaram entre 16 e 31 nos pacientes e foram 12 e 16 nos controles. A frequ\u00eancia de sintomas psiqui\u00e1tricos como um todo, foi significativamente maior nos hiperprolactin\u00eamicos (teste do qui-quadrado), mas a diferen\u00e7a n\u00e3o foi significativa na an\u00e1lise isolada de ansiedade ou depress\u00e3o. A hiperprolactinemia representa um fator de risco de 3,57 para depress\u00e3o, 3,32 para ansiedade e 3,84 para outros sintomas psiqui\u00e1tricos. N\u00e3o houve diferen\u00e7a significativa na frequ\u00eancia de sintomas psiqui\u00e1tricos entre portadores ou n\u00e3o de adenomas hipofis\u00e1rios e usu\u00e1rios ou n\u00e3o de bromocriptina. N\u00e3o houve correla\u00e7\u00e3o (r= 0,07) entre a prolactina e a frequ\u00eancia de sintomas psiqui\u00e1tricos. Conclui-se pela necessidade de atentar para a concomit\u00e2ncia de hiperprolactinemia e dist\u00farbios psiqui\u00e1tricos, cujo reconhecimento permitir\u00e1 abordagem terap\u00eautica espec\u00edfica.<\/jats:p>","DOI":"10.1590\/s0004-282x2000000400012","type":"journal-article","created":{"date-parts":[[2005,4,15]],"date-time":"2005-04-15T14:26:35Z","timestamp":1113575195000},"page":"671-676","source":"Crossref","is-referenced-by-count":16,"title":["Hiperprolactinemia e dist\u00farbios psiqui\u00e1tricos"],"prefix":"10.1590","volume":"58","author":[{"given":"MIRIAM C.","family":"OLIVEIRA","sequence":"first","affiliation":[{"name":"Santa Casa de Miseric\u00f3rdia de Porto Alegre; ISCMPA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CRISTINA BARDOU","family":"PIZARRO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LENARA","family":"GOLBERT","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CRISTINA","family":"MICHELETTO","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00006250-197507000-00001","article-title":"Neuroendocrine dysfunction in galactorrhea-amenorrhea after oral contraceptive use","volume":"46","author":"Tyson JE","year":"1975","journal-title":"Obstet Gynecol","ISSN":"https:\/\/id.crossref.org\/issn\/0029-7844","issn-type":"print"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000287535","article-title":"Depression, hostility and anxiety in hyperprolactinemic amenorrhea","volume":"36","author":"Fava GA","year":"1981","journal-title":"Psychother Psychosom","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3190","issn-type":"print"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1176\/ajp.141.6.759","article-title":"Hyperprolactinemia, distress, and hostility","volume":"141","author":"Kellner R","year":"1984","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref4","series-title":"The pituitary","first-page":"136","volume-title":"Prolactin","author":"Molitch ME","year":"1995"},{"key":"ref5","series-title":"The Composed International Diagnostic Interview (CIDI)","year":"1990"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression","volume":"23","author":"Hamilton M","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3050","issn-type":"print"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000126686","article-title":"Prolactin, central nervous system and behavior: a critical review","volume":"59","author":"Dutt A","year":"1994","journal-title":"Neuroendocrinology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3835","issn-type":"print"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000287575","article-title":"Psychological correlates of hyperprolactinemia in males","volume":"37","author":"Fava M","year":"1982","journal-title":"Psychother Psychosom","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3190","issn-type":"print"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1176\/ajp.144.8.1037","article-title":"Effect of bromocriptine on affect and libido in hyperprolactinemia","volume":"144","author":"Koppelman MCS","year":"1987","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1176\/ajp.142.2.242","article-title":"Reduction of distress in hyperprolactinemia with bromocriptine","volume":"142","author":"Buckman MT","year":"1985","journal-title":"Am J Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0002-953X","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000012273","article-title":"Emotional aspects of hyperprolactinemia","volume":"67","author":"Sobrinho LG","year":"1988","journal-title":"Psychother Psychosom","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3190","issn-type":"print"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1530\/acta.0.109S118","article-title":"Psychological correlates of prolactin secretion: aggression and depression","volume":"108","author":"Keller SK","year":"1985","journal-title":"Acta Endocrinol","ISSN":"https:\/\/id.crossref.org\/issn\/0001-5598","issn-type":"print"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1046\/j.1365-2265.1997.2701073.x","article-title":"Psychological distress in patients with hyperprolactinaemia","volume":"47","author":"Reavley A","year":"1997","journal-title":"Clin Endocrinol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000287773","article-title":"Psychosomatic aspects of hyperprolactinemia","volume":"40","author":"Fava M","year":"1983","journal-title":"Psychother Psychosom","ISSN":"https:\/\/id.crossref.org\/issn\/0033-3190","issn-type":"print"},{"key":"ref15","first-page":"694","article-title":"Dopamine agonists for reducing depression associated with hyperprolactinemia","volume":"31","author":"Mattox JH","year":"1986","journal-title":"J Reprod Med","ISSN":"https:\/\/id.crossref.org\/issn\/0024-7758","issn-type":"print"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0015-0282(16)55201-7","article-title":"The effect of two dopaminergic drugs on menstrual function and psychological state in hyperprolactinemia","volume":"58","author":"Lapp\u00f6hn RE","year":"1992","journal-title":"Fertil Steril","ISSN":"https:\/\/id.crossref.org\/issn\/0015-0282","issn-type":"print"},{"key":"ref17","first-page":"830","article-title":"Bromocriptine as antidepressant: double-blind comparative study with imipramine in psychogenic and endogenous depression","volume":"30","author":"Teohar C","year":"1981","journal-title":"Curr Ther Res"},{"key":"ref18","first-page":"68","volume":"51","author":"Sitland-Marken PA","year":"1990","journal-title":"J Clin Psychiatry","ISSN":"https:\/\/id.crossref.org\/issn\/0160-6689","issn-type":"print"},{"key":"ref19","series-title":"Principles and practice of endocrinology and metabolism","first-page":"223","volume-title":"Medical treatment of pituitary tumors and hypersecretory states","author":"Sarne DH","year":"1995"}],"container-title":["Arquivos de Neuro-Psiquiatria"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/anp\/v58n3a\/2557.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,13]],"date-time":"2019-02-13T16:30:07Z","timestamp":1550075407000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0004-282X2000000400012&lng=pt&tlng=pt"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9]]},"references-count":19,"journal-issue":{"issue":"3A","published-print":{"date-parts":[[2000,9]]}},"alternative-id":["S0004-282X2000000400012"],"URL":"https:\/\/doi.org\/10.1590\/s0004-282x2000000400012","relation":{},"ISSN":["0004-282X"],"issn-type":[{"value":"0004-282X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9]]}}}